RecruitingPhase 3NCT02064673
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Randomized Trial of Adjuvant Curcumin After Prostatectomy
Sponsor
yair lotan
Enrollment
650 participants
Start Date
May 1, 2014
Study Type
INTERVENTIONAL
Conditions
Summary
This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.
Eligibility
Sex: MALEMin Age: 30 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether taking curcumin — a natural compound found in turmeric with anti-inflammatory properties — after surgery for colon cancer can help prevent the cancer from coming back.
**You may be eligible if...**
- You have been diagnosed with colon cancer and had surgery to remove the tumor
- There is no evidence that cancer remains after surgery
- You are willing to take a daily curcumin supplement for an extended period
- You are at least 18 years old and in reasonably good health
- Your liver and kidney function are within normal ranges
**You may NOT be eligible if...**
- You have had prior chemotherapy or radiation therapy for colon cancer before surgery
- You have signs that cancer is still present after surgery
- You have significant gastrointestinal conditions (such as inflammatory bowel disease) that might affect how you absorb the supplement
- You are pregnant or breastfeeding
- You are taking medications that could interact significantly with curcumin (such as blood thinners)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGCurcumin
Curcumin or placebo 500mg by mouth twice a day for 6 months
DRUGplacebo
placebo orally twice a day
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02064673
Related Trials
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
NCT0719261425 locations
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
NCT048084271 location
Collection of Blood From Patients With Prostate Cancer
NCT009232211 location
Electric Cardiometry-Guided Standard Versus Restricted Fluid Therapy In Robotic Prostaectomy
NCT076261511 location
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
NCT075355411 location